Skip to main content
Clinical Trials/NCT02033772
NCT02033772
Completed
Not Applicable

Prospective Data Collection of Patients < 6 Months of Age Undergoing Thoracoscopic Surgery

Arlyne Thung1 site in 1 country17 target enrollmentAugust 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Congenital Diaphragmatic Hernia
Sponsor
Arlyne Thung
Enrollment
17
Locations
1
Primary Endpoint
Change in transcutaneous CO2
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

The study is primarily a descriptive study examining the physiological, ventilatory, surgical, and recovery effects of patients ≤ 6 months of age who undergo thoracoscopic surgery and to determine the accuracy of transcutaneous CO2 (TC-CO2) and end-tidal CO2 (ET-CO2) during high frequency oscillatory ventilation (HFOV) and thoracoscopic procedures.

Registry
clinicaltrials.gov
Start Date
August 2013
End Date
October 6, 2017
Last Updated
8 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Arlyne Thung
Responsible Party
Sponsor Investigator
Principal Investigator

Arlyne Thung

Assistant Clinical Professor

Nationwide Children's Hospital

Eligibility Criteria

Inclusion Criteria

  • Patients presenting for thoracoscopic surgery
  • Patients aged ≤ 6 months of age

Exclusion Criteria

  • Patients presenting for any procedure other than thoracoscopic surgery
  • Patients aged \> 6 months of age

Outcomes

Primary Outcomes

Change in transcutaneous CO2

Time Frame: Duration of surgery, average of 3 hours.

Secondary Outcomes

  • Change in blood pressure(Duration of surgery, average of 3 hours.)
  • Change in ET-CO2(Duration of surgery, average of 3 hours.)
  • Change in SpO2(Duration of surgery, average of 3 hours.)
  • Change in heart rate(Duration of surgery, average of 3 hours.)

Study Sites (1)

Loading locations...

Similar Trials